Theravance Biopharma Inc (TBPH)
Net Receivables
$20.38M
Quarterly · Period ending: · USD
TBPH Net Receivables
Latest reported$20.38Mperiod ending
Latest reported$20.38Mperiod ending
TBPH Quarterly Net Receivables ($941.00K → $20.38M)
Quarterly net receivables
High-resolution chart · PNG
TBPH net receivables history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 20,381,000 | |
| 15,584,000 | |
| 95,539,000 | |
| 18,267,000 | |
| 21,919,000 | |
| 15,353,000 | |
| 68,440,000 | |
| 16,845,000 | |
| 14,299,000 | |
| 14,664,000 | |
| 17,474,000 | |
| 17,057,000 | |
| 15,796,000 | |
| 12,270,000 | |
| 16,785,000 | |
| 14,114,000 | |
| 12,488,000 | |
| 12,277,000 | |
| 57,599,000 | |
| 14,001,000 | |
| 39,961,000 | |
| 11,915,000 | |
| 69,667,000 | |
| 61,308,000 | |
| 46,922,000 | |
| 41,696,000 | |
| 50,570,000 | |
| 9,277,000 | |
| 111,000 | |
| 7,937,000 | |
| 10,673,000 | |
| 6,931,000 | |
| 7,299,000 | |
| 4,818,000 | |
| 9,362,000 | |
| 13,123,000 | |
| 6,664,000 | |
| 8,872,000 | |
| 9,722,000 | |
| 23,586,000 | |
| 36,936,000 | |
| 39,063,000 | |
| 37,154,000 | |
| 20,423,000 | |
| 26,293,000 | |
| 20,225,000 | |
| 2,129,000 | |
| 411,000 | |
| 94,000 | |
| 93,000 | |
| 1,133,000 | |
| 2,423,000 | |
| 1,896,000 | |
| 1,963,000 | |
| 941,000 |